1. Home
  2. VTRS vs QBTS Comparison

VTRS vs QBTS Comparison

Compare VTRS & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • QBTS
  • Stock Information
  • Founded
  • VTRS 1961
  • QBTS 1999
  • Country
  • VTRS United States
  • QBTS United States
  • Employees
  • VTRS N/A
  • QBTS N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • QBTS Retail: Computer Software & Peripheral Equipment
  • Sector
  • VTRS Health Care
  • QBTS Technology
  • Exchange
  • VTRS Nasdaq
  • QBTS Nasdaq
  • Market Cap
  • VTRS 11.1B
  • QBTS 9.0B
  • IPO Year
  • VTRS N/A
  • QBTS N/A
  • Fundamental
  • Price
  • VTRS $10.37
  • QBTS $32.77
  • Analyst Decision
  • VTRS Hold
  • QBTS Strong Buy
  • Analyst Count
  • VTRS 6
  • QBTS 10
  • Target Price
  • VTRS $11.17
  • QBTS $20.50
  • AVG Volume (30 Days)
  • VTRS 7.1M
  • QBTS 69.1M
  • Earning Date
  • VTRS 11-06-2025
  • QBTS 11-06-2025
  • Dividend Yield
  • VTRS 4.64%
  • QBTS N/A
  • EPS Growth
  • VTRS N/A
  • QBTS N/A
  • EPS
  • VTRS N/A
  • QBTS N/A
  • Revenue
  • VTRS $14,115,700,000.00
  • QBTS $22,275,000.00
  • Revenue This Year
  • VTRS N/A
  • QBTS $183.72
  • Revenue Next Year
  • VTRS $1.61
  • QBTS $55.91
  • P/E Ratio
  • VTRS N/A
  • QBTS N/A
  • Revenue Growth
  • VTRS N/A
  • QBTS 120.20
  • 52 Week Low
  • VTRS $6.85
  • QBTS $0.98
  • 52 Week High
  • VTRS $13.55
  • QBTS $46.75
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 61.57
  • QBTS 52.59
  • Support Level
  • VTRS $10.30
  • QBTS $26.37
  • Resistance Level
  • VTRS $10.52
  • QBTS $39.68
  • Average True Range (ATR)
  • VTRS 0.21
  • QBTS 4.93
  • MACD
  • VTRS 0.05
  • QBTS -1.31
  • Stochastic Oscillator
  • VTRS 81.82
  • QBTS 31.40

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Share on Social Networks: